KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Medpace Holdings (MEDP) EBIAT: 2015-2025

Historic EBIAT for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $111.1 million.

  • Medpace Holdings' EBIAT rose 15.25% to $111.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $433.0 million, marking a year-over-year increase of 18.42%. This contributed to the annual value of $404.4 million for FY2024, which is 42.99% up from last year.
  • Per Medpace Holdings' latest filing, its EBIAT stood at $111.1 million for Q3 2025, which was up 23.13% from $90.3 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' EBIAT registered a high of $117.0 million during Q4 2024, and its lowest value of $39.9 million during Q2 2021.
  • For the 3-year period, Medpace Holdings' EBIAT averaged around $91.2 million, with its median value being $90.3 million (2025).
  • The largest annual percentage gain for Medpace Holdings' EBIAT in the last 5 years was 65.67% (2021), contrasted with its biggest fall of 1.64% (2021).
  • Quarterly analysis of 5 years shows Medpace Holdings' EBIAT stood at $50.0 million in 2021, then skyrocketed by 37.25% to $68.7 million in 2022, then increased by 14.02% to $78.3 million in 2023, then surged by 49.45% to $117.0 million in 2024, then climbed by 15.25% to $111.1 million in 2025.
  • Its EBIAT was $111.1 million in Q3 2025, compared to $90.3 million in Q2 2025 and $114.6 million in Q1 2025.